Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BCDA

BioCardia (BCDA)

BioCardia Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCDA
DateTimeSourceHeadlineSymbolCompany
15/05/202406:02GlobeNewswire Inc.BioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:BCDABioCardia Inc
01/05/202421:00GlobeNewswire Inc.BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesNASDAQ:BCDABioCardia Inc
25/04/202423:00GlobeNewswire Inc.BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In CohortNASDAQ:BCDABioCardia Inc
28/03/202407:00GlobeNewswire Inc.BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial ResultsNASDAQ:BCDABioCardia Inc
20/03/202422:00GlobeNewswire Inc.BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024NASDAQ:BCDABioCardia Inc
13/03/202422:00GlobeNewswire Inc.BioCardia and StemCardia Announce Biotherapeutic Delivery PartnershipNASDAQ:BCDABioCardia Inc
12/03/202422:00GlobeNewswire Inc.BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure StudyNASDAQ:BCDABioCardia Inc
05/03/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
05/03/202400:00GlobeNewswire Inc.BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart FailureNASDAQ:BCDABioCardia Inc
28/02/202408:53Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCDABioCardia Inc
15/02/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCDABioCardia Inc
15/02/202409:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCDABioCardia Inc
15/02/202408:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCDABioCardia Inc
10/02/202401:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
08/02/202423:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
08/02/202423:00GlobeNewswire Inc.BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDANASDAQ:BCDABioCardia Inc
07/02/202408:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCDABioCardia Inc
03/02/202406:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCDABioCardia Inc
31/01/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
31/01/202423:00GlobeNewswire Inc.BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics ConferenceNASDAQ:BCDABioCardia Inc
03/01/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
03/01/202423:00GlobeNewswire Inc.BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for ShareholdersNASDAQ:BCDABioCardia Inc
19/12/202323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
19/12/202323:00GlobeNewswire Inc.BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection FractionNASDAQ:BCDABioCardia Inc
18/12/202323:16GlobeNewswire Inc.BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation MinutesNASDAQ:BCDABioCardia Inc
18/12/202323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
06/12/202322:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
06/12/202322:03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCDABioCardia Inc
06/12/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCDABioCardia Inc
06/12/202308:11Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BCDABioCardia Inc
 Showing the most relevant articles for your search:NASDAQ:BCDA

Your Recent History

Delayed Upgrade Clock